<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="34502">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02657421</url>
  </required_header>
  <id_info>
    <org_study_id>P15-05</org_study_id>
    <nct_id>NCT02657421</nct_id>
  </id_info>
  <brief_title>OLIF25™ /OLIF51™ Study</brief_title>
  <official_title>A Multi-Center, Prospective, Observational Study to Assess Outcomes for Patients Treated for Lumbar Spinal Conditions Using an OLIF25™ and/or OLIF51™Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Spinal and Biologics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Spinal and Biologics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this single-arm observational study is to observe and document clinical
      outcomes of the OLIF25™ and OLIF51™ procedures in patients diagnosed with degenerative disc
      disease or degenerative scoliosis, and report the rate of adverse events of interest through
      the 24 months follow-up visit.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>24 Months</target_duration>
  <primary_outcome>
    <measure>Back and Leg Pain Measured by Visual Analogue Scales (VAS)</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry Disability Index (ODI)</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>European Quality of Life-5 Dimensions (EQ-5D) self-report questionnaire</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurological deficits assessed by neurological status</measure>
    <time_frame>24 months</time_frame>
    <description>Neurological status is based on seven components of measurements: Motor function; Sensory function; Deep Tendon reflexes; Sympathetic Exam; Claudication; Urinary bladder retention/Bowel retention; and Sexual Dysfunction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of adverse events</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>Surgical Data</measure>
    <time_frame>Day 0 to Day 5</time_frame>
    <description>Surgical data include mean blood loss, operative time, and length of hospital stay (LOS).</description>
  </other_outcome>
  <other_outcome>
    <measure>Work status</measure>
    <time_frame>24 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Spino-Pelvic Measurements by X-ray</measure>
    <time_frame>24 months</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <condition>Scoliosis</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oblique Lateral Interbody Fusion</intervention_name>
    <description>The oblique lateral interbody fusion (OLIF) procedures at L2-L5 (OLIF25™) and L5-S1 (OLIF51™) is a minimally invasive surgical option for degenerative lumbar disease. This approach allows for psoas-preserving access to the lumbar spine and minimizes the need to reposition the patient during surgery for accessing additional spinal levels for the interbody fusion portion of the procedure</description>
    <other_name>OLIF</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have surgery from L2-L5 for OLIF25™ and/or from L5-S1 for OLIF51™ for
        degenerative disc disease or degenerative scoliosis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is 18 years of age or older.

          2. Patient agrees to participate in the study and is able to sign the informed
             consent/data release form.

          3. Patient is undergoing surgery from L2-L5 for OLIF25™ and/or from L5-S1 for OLIF51™
             for degenerative disc disease or degenerative scoliosis.

        Exclusion Criteria:

        1. Illiterate or vulnerable patients (e.g. minors, participants incapable of judgment).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Advanced Neurosurgery Associates</name>
      <address>
        <city>Murrieta</city>
        <state>California</state>
        <zip>92563</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco (UCSF)</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Erika Cavallone</last_name>
      <phone>415-353-2240</phone>
    </contact>
    <investigator>
      <last_name>Dean Chou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The B.A.C.K. Center</name>
      <address>
        <city>Melbourne</city>
        <state>Florida</state>
        <zip>32901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Sellati</last_name>
      <phone>321-541-1587</phone>
    </contact>
    <investigator>
      <last_name>Richard Hynes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Devin Datta, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Foundation for Orthopaedic Research and Education (FORE)</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>NewYork-Presbyterian/The Allen Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10034</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zachary Messer</last_name>
      <phone>212-932-4410</phone>
    </contact>
    <investigator>
      <last_name>Ronald Lehman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alleghany Health Network Research Institute</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matt Yeager</last_name>
      <phone>412-359-4272</phone>
    </contact>
    <investigator>
      <last_name>Michael Oh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FN Ostrava</name>
      <address>
        <city>Ostrava</city>
        <state>Poruba</state>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Mruzek, MD</last_name>
      <phone>+42(0) 597 375 454</phone>
    </contact>
    <investigator>
      <last_name>Michael Mruzek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Du Mail</name>
      <address>
        <city>La Rochelle</city>
        <zip>17000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joelle Delhoume</last_name>
      <phone>+33 626656480</phone>
    </contact>
    <investigator>
      <last_name>Samuel d'Houtaud, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CUF Descobertas</name>
      <address>
        <city>Lisbon</city>
        <zip>1998-018</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joao Cannas, MD</last_name>
      <phone>+351 916 741 642</phone>
    </contact>
    <investigator>
      <last_name>Joao Cannas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orthospine Group</name>
      <address>
        <city>San Juan</city>
        <zip>00910-3428</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>YoMary Montiel</last_name>
      <phone>787-766-7070</phone>
    </contact>
    <investigator>
      <last_name>Yamil Rivera-Colon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czech Republic</country>
    <country>France</country>
    <country>Portugal</country>
    <country>Puerto Rico</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 16, 2017</lastchanged_date>
  <firstreceived_date>January 11, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Scoliosis</mesh_term>
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
